Table 3.
Characteristics of the studies
| References | Global region | Imaging | Subjects | Tarlov cyst incidence (%) |
|---|---|---|---|---|
| Burdan et al. [2] | Europe | MRI | 842 | 8.91 |
| Gleeson et al. [4] | Europe | MRI | 260 | 0.38 |
| Gopalakrishnan et al. [5] | Asia | MRI | 200 | 1.00 |
| Jeong et al. [9] | Asia | MRI | 494 | 10.73 |
| Joo et al. [10] | Asia | MRI | 2669 | 1.72 |
| Komisaruk and Lee [11]* | North America | MRI | 18 | 66.67 |
| Kuhn et al. [12] | Europe | MRI | 1100 | 12.00 |
| Langdown et al. [13] | Europe | MRI | 3535 | 1.53 |
| Larsen et al. [14] | Europe | Myelography | 136 | 17.65 |
| Lim et al. [15] | North America | MRI | 242 | 16.12 |
| Oaklander et al. [17]* | North America | MRI | 10 | 50.00 |
| Park et al. [18] | Asia | MRI | 1268 | 2.13 |
| Paulsen et al. [19] | North America | MRI | 500 | 4.60 |
| Petrasic et al. [20] | North America | MRI | 185 | 1.62 |
| Pink et al. [21]* | North America | MRI | 15 | 6.67 |
| Ramadorai et al. [23] | North America | MRI | 67 | 1.49 |
| Ramirez et al. [24] | North America | MRI | 261 | 0.38 |
| Senoglu et al. [25] | Asia | MRI | 1000 | 1.30 |
| Shi et al. [26] | Asia | MRI | 75 | 2.67 |
| Tani et al. [27] | Asia | MRI | 102 | 9.80 |
| Zacharakis et al. [28] | Europe | MRI | 30 | 6.67 |
| Zeitoun et al. [29] | Asia | MRI | 217 | 0.46 |
Excluded from estimation of the general pooled prevalence, included only in subgroup analysis
*Patients with persistent genital arousal disorder